Alectinib Promising In Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Treatment
News
A recent study published in the Journal of Thoracic Oncology demonstrated that patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) responded positively to treatment with alectinib, an ... Read more